Floatz logo

AUTOLOGOUS HUMAN PERIPHERAL BLOOD LYMPHOCYTES (PRIMARILY T-CELLS, EXPANDED WITH IL-2, CD3/CD28 BEADS)

B-cell Acute Lymphoblastic Leukemia

Beijing GoBroad HospitalCell therapyN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
73/ 100

Competitive context

140 Active assets in the B-cell Acute Lymphoblastic Leukemia cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
University of Washington
Phase 3BBB
VINCRISTINE SULFATE
City of Hope Medical Center
Phase 3BB
ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)
City of Hope Medical Center
Phase 3BB
MERCAPTOPURINE ANHYDROUS
SWOG Cancer Research Network
Phase 3BB
PEGASPARGASE
National Cancer Institute (NCI)
Phase 3BB

View all 50 →

Same molecule, other indications

AUTOLOGOUS HUMAN PERIPHERAL BLOOD LYMPHOCYTES (PRIMARILY T-CELLS, EXPANDED WITH IL-2, CD3/CD28 BEADS) is also rated in:

chronic lymphocytic leukemia/small lymphocytic lymphomaDormant
CC
Indicative ·
40 / 100
View asset →
acute lymphoblastic leukemiaDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →